ClearNote Health
United States
- San Diego, California
- 28/05/2026
- Series D
- $52,000,000
ClearNote Health – Cancer detection company enabling people at risk for high-mortality cancers to live longer, healthier lives.
We focus on developing non-invasive tests to detect cancer through a standard blood draw earlier than existing methods by harnessing the power of epigenomics. We apply our proprietary epigenomic platform, combining biology and artificial intelligence, to identify DNA-based changes in biology as cancer develops.
With lead programs in non-invasive early detection of pancreatic and ovarian cancers in patients at the highest risk for these diseases. Headquartered in the U.S, the company’s CLIA and CAP-accredited laboratory is located in San Diego, Calif., with additional presence in the San Francisco Bay Area and internationally.
#biotechnology #epigenomics #oncology #cancerresearch #cancer
- Industry Biotechnology Research
- Website https://www.clearnotehealth.com/
- LinkedIn https://www.linkedin.com/company/clearnotehealth/
Related People
Dave MullarkeyFounder
United States -
Menlo Park, California
I build strategies to drive growth and profitability in demanding and complex markets, guide efforts across product development, business development and commercial while thriving in chaotic environments, bringing stability and a path forward to favorable outcomes. I deliver shareholder value growth and build investor and stakeholder relationships to enable fundraising, critical to fostering scalability. As a calculated risk taker, I empower team members to overcome business challenges and deliver results from R&D to commercialization stages of products/services. I utilize strategic thinking and deep market understanding and identify new revenue growth opportunities. I establish and execute against strategic priorities for multi-faceted organizations, while leading large, diverse teams and building positive corporate culture.
Itera | $12,000,000 | (May 28, 2026)
ClearNote Health | $52,000,000 | (May 28, 2026)
Protuoso Biosciences | $9,500,000 | (May 28, 2026)
ClearOps | $10,009,454 | (May 27, 2026)
NavigateAI | $25,000,000 | (May 27, 2026)
Go Swag | $5,000,000 | (May 27, 2026)
Hardline | $2,000,000 | (May 27, 2026)
Squid | $6,000,000 | (May 27, 2026)
Quartermaster | $43,000,000 | (May 27, 2026)
OpenRouter | $113,000,000 | (May 27, 2026)